Business Context and Reporting Period
This Form 8-K Current Report was filed by Aflac Incorporated on November 14, 2017. The filing addresses significant changes in corporate leadership and board composition effective December 31, 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance changes rather than financial performance.
Material Changes
- Resignation of President: Kriss Cloninger III will resign as President of Aflac Incorporated effective December 31, 2017.
- Board Retirement: Mr. Cloninger will also retire as a member of the Board of Directors effective the close of business on December 31, 2017.
- New Board Appointment: The Board appointed Katherine T. Rohrer as a director effective immediately on November 14, 2017. Her term will expire at the 2018 Annual Meeting of Shareholders.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. Regarding the new director, Dr. Rohrer will receive compensation and participate in plans consistent with the Company's non-employee director compensation practices described in the Annual Proxy Statement filed on March 16, 2017. Specific committee assignments for Dr. Rohrer have not yet been determined.
Key Facts for Investor Verification
- Confirm the effective date of Kriss Cloninger III's departure from both the President role and the Board (December 31, 2017).
- Verify the immediate appointment of Katherine T. Rohrer to the Board and her term expiration date (2018 Annual Meeting).
- Review the Company's Annual Proxy Statement (filed March 16, 2017) for details on non-employee director compensation applicable to Dr. Rohrer.
- Monitor future filings for the announcement of Dr. Rohrer's specific Board committee assignments.